Pages that link to "Q27472927"

The following pages link to A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques (Q27472927):

Displaying 47 items.

• Dendritic cell-based immunity and vaccination against hepatitis C virus infection (Q26828003) ‎ (← links)
• Circumventing antivector immunity: potential use of nonhuman adenoviral vectors (Q26995655) ‎ (← links)
• Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections (Q27485491) ‎ (← links)
• Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and [...] (Q27486582) ‎ (← links)
• Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors (Q28731894) ‎ (← links)
• Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. (Q30368699) ‎ (← links)
• Immunotherapy for HCV infection: next steps. (Q30371832) ‎ (← links)
• Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses (Q33602744) ‎ (← links)
• Hepatitis C vaccine: supply and demand (Q34011890) ‎ (← links)
• Computational analysis of two species C human adenoviruses provides evidence of a novel virus (Q34208753) ‎ (← links)
• Characterization of species C human adenovirus serotype 6 (Ad6) (Q34669375) ‎ (← links)
• Will there be a vaccine to prevent HCV infection? (Q34781537) ‎ (← links)
• Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes (Q35576891) ‎ (← links)
• Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon (Q35949758) ‎ (← links)
• Gene therapy for viral hepatitis. (Q36708296) ‎ (← links)
• Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates (Q36759754) ‎ (← links)
• Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species (Q36768279) ‎ (← links)
• T-cell immunity generated by recombinant adenovirus vaccines (Q36837129) ‎ (← links)
• Macaque models of human infectious disease (Q37103536) ‎ (← links)
• Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Q37349242) ‎ (← links)
• Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents (Q37442235) ‎ (← links)
• Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus (Q37452136) ‎ (← links)
• Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockade (Q37539241) ‎ (← links)
• Adenoviral producer cells (Q37945217) ‎ (← links)
• Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities (Q37997825) ‎ (← links)
• Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials. (Q38096490) ‎ (← links)
• Electroporation-enhanced delivery of nucleic acid vaccines (Q38285418) ‎ (← links)
• Progress in the development of vaccines for hepatitis C virus infection (Q38635596) ‎ (← links)
• Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5 (Q38714311) ‎ (← links)
• The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China (Q39346309) ‎ (← links)
• Getting genetic access to natural adenovirus genomes to explore vector diversity (Q39437315) ‎ (← links)
• Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates (Q39823165) ‎ (← links)
• Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. (Q39866377) ‎ (← links)
• Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence (Q40197794) ‎ (← links)
• Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates (Q40205686) ‎ (← links)
• A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity (Q40379142) ‎ (← links)
• Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160. (Q42282236) ‎ (← links)
• Adenoviruses isolated from wild gorillas are closely related to human species C viruses (Q42287685) ‎ (← links)
• Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes (Q42999099) ‎ (← links)
• Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy (Q47738795) ‎ (← links)
• International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials (Q56447686) ‎ (← links)
• Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine (Q57078036) ‎ (← links)
• Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections (Q60046851) ‎ (← links)
• Progress in Adenoviral Capsid-Display Vaccines (Q64376803) ‎ (← links)
• Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route (Q90461228) ‎ (← links)
• Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus (Q92538245) ‎ (← links)
• Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans (Q100751547) ‎ (← links)